Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity. | Autophagy | 2025 | 40568844 | PubTator, text mining | PubMed |
| The Association Between Dexmedetomidine and Bradycardia: An Analysis of FDA Adverse Event Reporting System (FAERS) Data and Transcriptomic Profiles. | Genes (Basel) | 2025 | 40565507 | PubTator, text mining | PubMed |
| GPR55 senses lactate to sustain motility in prostate cancer cells. | Mol Cell Biochem | 2025 | 40434517 | PubTator, text mining | PubMed |
| Heterogeneous Dysregulation of Myosin Super-Relaxation and Energetics in Hypertrophic Cardiomyopathy. | Circ Heart Fail | 2025 | 40391807 | PubTator, text mining | PubMed |
| ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment'. | Eur Heart J Suppl | 2025 | 40385469 | PubTator, text mining | PubMed |
| Traditional Chinese medicine for sepsis: advancing from evidence to innovative drug discovery. | Crit Care | 2025 | 40375087 | PubTator, text mining | PubMed |
| NEK2 inhibition alleviates lipopolysaccharide-induced endothelial injury. | ASPET Discov | 2025 | 40259950 | PubTator, text mining | PubMed |
| Evaluation of specific lncRNAs, miRNAs, and mRNAs in different groups of prostate cancer. | Bioimpacts | 2025 | 40256234 | PubTator, text mining | PubMed |
| Homoharringtonine (omacetaxine mepesuccinate) limits the angiogenic capacity of endothelial cells and reorganises filamentous actin. | Biomed Pharmacother | 2025 | 40184838 | PubTator, text mining | PubMed |
| Study on the changes of extracellular matrix morphology and components in COPD animal model by using lung decellularized scaffold. | FASEB J | 2025 | 40150895 | PubTator, text mining | PubMed |
| The Minute Virus of Canines (MVC) Activates the RhoA/ROCK1/MLC2 Signal Transduction Pathway Resulting in the Dissociation of Tight Junctions and Facilitating Occludin-Mediated Viral Infection. | Microorganisms | 2025 | 40142587 | PubTator, text mining | PubMed |
| Thrombospondin 1 Promotes Cytoskeleton Remodeling, Dedifferentiation, and Pulmonary Metastasis through ITGA1 and ITGA6 in Osteosarcoma. | Int J Biol Sci | 2025 | 40083708 | PubTator, text mining | PubMed |
| Differential impact of substrates on myosin heavy and light chain expression in human stem cell-derived cardiomyocytes at single-cell level. | J Muscle Res Cell Motil | 2025 | 39948277 | PubTator, text mining | PubMed |
| Promoting the transition from pyroptosis to apoptosis in endothelial cells: a novel approach to alleviate methylglyoxal-induced vascular damage. | J Transl Med | 2025 | 39930472 | PubTator, text mining | PubMed |
| Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway. | Adv Sci (Weinh) | 2025 | 39888301 | PubTator, text mining | PubMed |
| LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression. | Transl Oncol | 2025 | 39874729 | PubTator, text mining | PubMed |
| Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome. | PLoS One | 2025 | 39854311 | PubTator, text mining | PubMed |
| Network analysis of differentially expressed genes involved in oral submucous fibrosis and oral squamous cell carcinoma: a comparative approach. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2025 | 39779388 | PubTator, text mining | PubMed |
| Exploring genetic mapping and co-expression patterns to illuminate significance of Tbx20 in cardiac biology. | Transgenic Res | 2025 | 39777589 | PubTator, text mining | PubMed |
| Long term Coptidis Rhizoma intake induce gastrointestinal emptying inhibition and colon barrier weaken via bitter taste receptors activation in mice. | Phytomedicine | 2025 | 39631296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=5